Navigation Links
Emerging staph strains found to be increasingly deadly and deceptive

with certain strains," says Jovanka Voyich, Ph.D., of RML, the study's lead author. To cause human disease, bacterial pathogens must avoid being killed by neutrophils. "These results," says Dr. Voyich, "suggest that community-acquired MRSA causes disease in healthy people in part because it has enhanced ability to circumvent killing by neutrophils."


'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3

Related biology news :

1. Ticks, flukes, and genomics: Emerging pathogens revealed
2. Substance protects resilient staph bacteria
3. Study indicates dramatic rise in antibiotic-resistant community-acquired staph infections
4. Less virulent strains of avian influenza can infect humans
5. Study outlines genetic differences between potential pandemic influenza strains
6. Human behavior changes the number of strains of infectious diseases
7. Experimental vaccine protects lab animals against several strains of H5N1
8. Complexity constrains evolution of human brain genes
9. New test for most virulent HPV strains under study
10. New component of the brakes on nerve regeneration found
11. Strongest proof yet found for prion hypothesis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Emerging staph strains found increasingly deadly and deceptive

(Date:5/22/2013)... and engineers must join together in a major new ... a crisis in providing Earth,s people with clean water ... focus of a comment article in the current edition ... newsmagazine of the American Chemical Society (ACS), the world,s ... L. Sedlak, Ph.D., and Jerald L. Schnoor, Ph.D., explain ...
(Date:5/22/2013)... drastically reduces the time and effort needed to ... biotechnology, scientists are reporting. Published in the journal ... the way for more rapid development of designer ... activities. , Keith Shearwin and colleagues explain that ... material DNA into a bacterium,s genome is critical ...
(Date:5/22/2013)... can endanger the whole organism, as they may lead ... in Munich now report how byproducts of respiration cause ... DNA in our cells controls the form and function ... for this are encoded in the linear sequence of ... (A), cytosine (C), guanine (G) and thymine (T). Random ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2
... much difference can a tenth of a nanometer make? When ... in resolution of that miniscule amount can mean the difference ... Case in point: New, improved-resolution views of a zinc ... National Laboratory provide not just a structure but also a ...
... cells to turn into disease-fighting ,Natural Killer, (NK) immune cells ... Nature Immunology today. The discovery could one day ... cells, creating new ways to treat cancer. The ... E4bp4, in a mouse model, creating the world,s first animal ...
... the flowers of Edinburgh in full bloom in the depths of ... impact of global warming on spring flowering, published today in the ... back to the late nineteenth century, has been used to demonstrate ... warming will have on plant life by the year 2080. ...
Cached Biology News:High-res view of zinc transport protein 2High-res view of zinc transport protein 3Master gene that switches on disease-fighting cells identified by scientists 2Master gene that switches on disease-fighting cells identified by scientists 3Early spring time for Edinburgh? Study predicts effect of global warming on spring flowers 2
(Date:5/23/2013)... 2013 The maker community is a ... inventions. They focus on learning practical skills while applying ... toward bringing their ideas to life via crowdfunding. A ... on making projects using biology. Glowing Plant has worked ... make them glow with bioluminescence genes, and has now ...
(Date:5/23/2013)... MENLO PARK, Calif. , May 23, 2013 /PRNewswire/ ... an oral treatment for pain has reached an important ... clinical trial of VBY-036 - a selective cathepsin S ... of VBY-036 is a double-blind, randomized, placebo-controlled study designed ... escalating doses of VBY-036 in healthy adults. ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... 2013 During the conduct of ... adhere to principles of good clinical practice (GCP) ... Dr. Jeremy Lim, Fellow, Clinical Development at Novartis ... ,     Understand the International Conference on Harmonization (ICH) ... regulations for the conduction of clinical trials , ...
Breaking Biology Technology:Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Adhering to Good Clinical Practice, New Webinar Hosted by Xtalks 2
... 13 /PRNewswire/-- DATATRAK International, Inc. (OTCQX: DATA), a technology and ... clinical trials industry, announced today that Zacks Investment Research ... 13, 2010. Zacks is a leading provider of independent ... report can be obtained by contacting Mr. Ken Nagy, ...
... 13 Matthew F. Heil, Ph.D., senior vice president of ... ), a drug research and development company focused on the ... Forum 2010 in Laval, Canada, at the invitation of the ... the Laval Technopole International Business Centre and The Biotech City ...
... BALTIMORE, Sept. 13 Champions Biotechnology, Inc. (OTC Bulletin Board: ... of advanced preclinical platforms and tumor specific data to enhance ... for the fiscal 2011 first quarter ended July 31, 2010. ... in the Company,s Form 10-Q at www.championsbiotechnology.com . ...
Cached Biology Technology:DATATRAK International, Inc. Announces Initial Equity Research Coverage by Zacks Investment Research 2DATATRAK International, Inc. Announces Initial Equity Research Coverage by Zacks Investment Research 3Curemark Attends North American Bio Forum at Canadian Government Invitation 2Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2011 First Quarter Financial Results 4
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells....
fli-1...
Purified Mouse anti-Hu p120 Catenin (pT916) Storage Temperature: Refrigerate(2 to 8C)...
Request Info...
Biology Products: